Monitoring of Injection Pressure During Regional Anesthesia in Pediatric Patient (COMPUFLO)

November 8, 2022 updated by: University Hospital, Montpellier

Use of Compuflo in Pediatric Anesthesia: Monitoring of Injection Pressure of Local Anesthetics in Children

A low injection pressure is one of the safety elements to check the correct position of the needle during regional anesthesia. Subjective assessment of pressure during manual injection of local anesthetic is most commonly used. In adults, the monitoring of the injection pressure has already been evaluated and makes it possible to objectify the pressure of the injection pressure. This is possible thanks to a device named Compuflo. No study has measured injection pressures during a regional anesthesia in children. The main objective is to control the injection pressures exercised in daily clinical practice during pediatric regional anesthesia with the Compuflo. Regional anesthesia will be proposed and explained during the anesthesia consultation. The procedure will be performed according to the habits of the anesthesiologist in charge of the patient. Only the addition of the Local Anesthetic Injection Pressure monitoring (Compuflo) to the needle changes the usual setup.

Study Overview

Status

Terminated

Detailed Description

The purpose of this study is to evaluate the usual practice using Compuflo, allowing the continuous measurement of the injection pressure of the local anesthetic at the needle level. On the day of the surgery, an anesthesiologist "operator" will realize the echo-guided regional anesthesia, qualifying aloud every injection realized (site or compartment of injection, and volume injected). An "observer" anesthesiologist will note the demographic data (age and weight), then the material data (minimum stimulation intensity, type and size of needles and syringes used), and finally he will note the maximum pressure levels reached during the injections performed.

Study Type

Interventional

Enrollment (Actual)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34380
        • University Hospital of Montpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Minor patient (0-16 years old) with consent of the major legal representative
  • Affiliated to the social security
  • Informed written consent, notification on the anesthesia sheet

Exclusion Criteria:

  • Patient over 16 years old
  • Patient under tutorship / curatorship
  • Young girl with known or suspected ongoing pregnancy
  • Known allergy to local anesthetics
  • Hemostatic disorder
  • Local infection at the puncture site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: device compuflo
injection pressure mesured by Compuflo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
injection pressure (injection pressure measured by Compuflo)
Time Frame: up to 24 hours (during the ALR)
injection pressure measured by Compuflo
up to 24 hours (during the ALR)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure values compared to the threshold value used in adults of 15 Psi
Time Frame: up to 24 hours (during the ALR)
Pressure values compared to the threshold value used in adults of 15 Psi
up to 24 hours (during the ALR)
Pressure values according to the different types of material used
Time Frame: up to 24 hours (during the ALR)
Pressure values according to the different types of material used
up to 24 hours (during the ALR)
Pressure values in the different infiltrated compartments
Time Frame: up to 24 hours (during the ALR)
Pressure values in the different infiltrated compartments
up to 24 hours (during the ALR)
Pressure values according to the age of the child
Time Frame: up to 24 hours (during the ALR)
Pressure values according to the age of the child
up to 24 hours (during the ALR)
Number and ratio of involuntary intra-neural injections
Time Frame: up to 24 hours (during the ALR)
Number and ratio of involuntary intra-neural injections
up to 24 hours (during the ALR)
Number and ratio of secondary paresthesias
Time Frame: up to 24 hours (during the ALR)
Number and ratio of secondary paresthesias
up to 24 hours (during the ALR)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 8, 2018

Primary Completion (Actual)

January 24, 2020

Study Completion (Actual)

January 24, 2020

Study Registration Dates

First Submitted

September 11, 2018

First Submitted That Met QC Criteria

September 11, 2018

First Posted (Actual)

September 14, 2018

Study Record Updates

Last Update Posted (Actual)

November 10, 2022

Last Update Submitted That Met QC Criteria

November 8, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL17_0399

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Locoregional Anesthesia

Clinical Trials on measure of injection pressure by compuflo

Subscribe